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Summary
Vertebrate female reproduction is limited by the oo-
cyte stockpiles acquired during embryonic develop-
ment. These are gradually depleted over the organ-
ism’s lifetime through the process of apoptosis. The
timer that triggers this cell death is yet to be identified.
We used the Xenopus egg/oocyte system to examine
the hypothesis that nutrient stores can regulate oocyte
viability. We show that pentose-phosphate-pathway
generation of NADPH is critical for oocyte survival
and that the target of this regulation is caspase-2, pre-
viously shown to be required for oocyte death in mice.
Pentose-phosphate-pathway-mediated inhibition of cell
death was due to the inhibitory phosphorylation of
caspase-2 by calcium/calmodulin-dependent protein
kinase II (CaMKII). These data suggest that exhaus-
tion of oocyte nutrients, resulting in an inability to
generate NADPH, may contribute to ooctye apopto-
sis. These data also provide unexpected links be-
tween oocyte metabolism, CaMKII, and caspase-2.
Introduction
Vertebrate female reproduction is limited by the oocyte
stockpiles acquired during embryonic development.
Apoptotic loss of oocytes over a lifetime leads ulti-
mately to loss of fertility (Tilly, 2001). In addition, patho-
logical insults or chemotherapeutic treatment can ac-
celerate oocyte death, resulting in premature oocyte
depletion and sterility (Perez et al., 1997). Despite the
importance of oocyte survival in determining female
fertility, the molecular pathways governing the timing of
apoptosis in these cells are not fully understood.
Genetic analyses in mice and in vitro experiments
using murine oocytes have provided a framework in
which to understand the molecular underpinnings of
oocyte apoptosis. Death of these cells can be pre-
vented by caspase inhibitors or antiapoptotic Bcl-2
proteins and induced by overexpression of either cas-
pases or proapoptotic Bcl-2 family members (Morita et
al., 1999; Morita and Tilly, 1999; Kim and Tilly, 2004;
Morita et al., 2000). Conclusions from such studies*Correspondence: kornb001@mc.duke.edu
5These authors contributed equally to this work.have been borne out by analyses of knockout mice in
which Bax-deficient animals exhibited a reduction in
oocyte apoptosis, with a consequent delay in oocyte
depletion (Perez et al., 1999), while mice lacking Bcl-2
or Bcl-xL had a decreased oocyte reserve (Ratts et al.,
1995; Watanabe et al., 1997).
Insight into oocyte apoptosis has come from studies
of knockout mice deficient in caspase-2. Surprisingly,
these mice developed normally, with one striking ex-
ception: female mice were endowed with an excess of
oocytes. Moreover, caspase-2-deficient oocytes were
markedly resistant to cell death induced by chemother-
apeutics (Bergeron et al., 1998). The precise role of cas-
pase-2 in cell death has been controversial, but recent
studies demonstrate that it can act upstream of the
mitochondria in a number of settings to trigger cyto-
chrome c release (Guo et al., 2002; Lassus et al., 2002;
Robertson et al., 2002). Caspase-2 is activated by bind-
ing to oligomerizing adaptor proteins. In response to
various stressors, caspase-2 is recruited into high-
molecular-weight complexes reminiscent of, though
distinct from, the Apaf-1/caspase-9 apoptosome (Read
et al., 2002). The caspase-2 prodomain can recruit an
adaptor protein, RAIDD, which, when overexpressed,
induces caspase-2 activation (Duan and Dixit, 1997).
Recently it was reported that p53 induces expression
of PIDD, a protein which promotes formation of a cas-
pase-2 activation complex containing PIDD, caspase-2,
and RAIDD (Tinel and Tschopp, 2004). It is not known
whether PIDD or RAIDD regulates caspase-2 in the
oocyte.
Although genetic analyses and microinjection studies
have provided critical information for understanding
oocyte apoptosis, most vertebrate oocytes are not
amenable to biochemical analysis due to their small
size and limited abundance. However, over a decade
ago, Newmeyer et al. reported that extracts prepared
from eggs of the frog, Xenopus laevis, could, upon pro-
longed incubation at room temperature, spontaneously
recapitulate many events of apoptosis, including mito-
chondrial cytochrome c release, caspase activation,
and nuclear fragmentation (Newmeyer et al., 1994). Im-
portantly, this in vitro apoptosis could be inhibited by
antiapoptotic Bcl-2 proteins and caspase inhibitors,
suggesting that at least some aspects of germ-cell
apoptosis are faithfully recapitulated in this system,
thereby providing a biochemically manipulable setting
in which to understand germ-cell apoptosis (Kluck et
al., 1997).
Despite the ease of manipulation of Xenopus eggs
and oocytes and the manifestation of apoptotic mark-
ers, it was not clear what might be driving apoptosis in
this system. Although initial reports suggested that the
timing of hormone administration used to elicit egg lay-
ing might determine the susceptibility of eggs to apo-
ptosis, research in the intervening years has failed to
establish a firm correlation between the rates of apo-
ptosis in Xenopus eggs and the hormonal regimen used
to obtain the eggs. Hence, we were driven to consider
other features of the oocyte/egg that might contribute
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90Figure 1. NADPH Is a Potent Inhibitor of Egg Apoptosis
(A) Xenopus egg extracts supplemented with G6P or buffer were analyzed for caspase-3 activity at various time points using the caspase
substrate Ac-DEVD-pNA. Substrate cleavage was measured spectrophotometrically at 405 nm. Cytochrome c release was measured in
parallel by filtering extract through a 0.1 m microfilter. The filtrate, lacking mitochondria, was analyzed by SDS-PAGE and immunoblotting
with anti-cytochrome c antibody. Blots were reprobed with anti-actin antibody.
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(B) Extracts treated as in (A) were supplemented with sperm nuclei and stained with Hoechst dye to detect DNA by fluorescence microscopy.
Shown are representative nuclei at the indicated times.
(C) Truncated Bid (tBid) was added to extract treated with G6P. Caspase-3 activity and cytochrome c release were measured as in (A).
(D) Buffer, glyceraldehyde-3-phosphate (G3P), pyruvate, or G6P was added to extract, and caspase-3 activity was measured.
(E) Pentose phosphate intermediates (NADPH, 6-phosphogluconate) or G6P was added to extract, and caspase-3 activity was measured.
(F) Malate was added to extracts, and caspase-3 activity and cytochrome c release were measured.
(G) A superoxide dismutase mimetic Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP) or a precursor to glutathione, N-acetyl-L-
cysteine (NAC), was added to extracts, and caspase activity was measured.
metabolized to 6-phosphogluconolactone and 6-phos-to cell-death regulation. In this regard, we were inter-
ested in the fact that oocytes are uniquely endowed
with a large stockpile of nutrients in the form of both
yolk proteins and glycogen stores, which are used to
sustain early embryonic development.
Numerous links have been established between me-
tabolism and apoptosis. For example, the Bcl-2 family
protein Bad associates with and regulates glucokinase/
hexokinase 4 (Danial et al., 2003). Moreover, AKT re-
quires glucose uptake to promote cell survival, and this
effect is exerted in part through targeting of hexokinase
to the mitochondria (Majewski et al., 2004; Rathmell et
al., 2003). In lymphocytes and neurons, growth-factor
withdrawal leads to a drop in glucose uptake and gly-
colytic rates prior to commitment to cell death (Deck-
werth and Johnson, 1993; Deshmukh et al., 1996; Rath-
mell et al., 2000; Vander Heiden et al., 2001). Moreover,
artificial maintenance of glycolysis confers some resis-
tance to cell death induced by cytokine withdrawal,
suggesting that active growth-factor signaling is re-
quired to maintain sufficient metabolism to prevent
death (Rathmell et al., 2001, 2003). In addition, glucose-
6-phosphate dehydrogenase activity, which promotes
the metabolism of glucose through the pentose phos-
phate pathway, can protect CHO cells from death in-
duced by ionizing radiation (Tuttle et al., 2000). Con-
versely, inhibition of both glycolytic and pentose
phosphate pathways can promote the apoptotic death
of some cultured cells (Comin-Anduix et al., 2002; Tian
et al., 1999; Tuttle et al., 2000). Thus, it was attractive
to hypothesize that nutrient stores in the oocyte might
support cell survival through modulation of metabolic
pathways. According to such a scenario, depletion of
energy stores within oocytes over time would result
either in loss of a critical survival pathway or the de novo
engagement of a cell-death pathway.
Here, using the facile biochemistry provided by the
Xenopus system, we report the identification and char-
acterization of a novel caspase-2 regulatory pathway
responsive to the metabolic state of the oocyte/egg.
We demonstrate that glucose-6-phosphate (G6P) suffi-
cient to drive continual operation of the pentose phos-
phate pathway can greatly prolong germ-cell survival.
Moreover, our data indicate that NADPH generation by
this pathway is critical for promoting survival and that
a surfeit of NADPH promotes a calcium/calmodulin-
dependent protein kinase II (CaMKII) dependent inhibi-
tory phosphorylation of caspase-2. Mutant caspase-2
resistant to CaMKII phosphorylation can circumvent
this metabolism-dependent suppression of apoptosis,
both in egg extracts and intact oocytes. These data,
which are fully consistent with the reported requirement
for caspase-2 in mouse oocyte apoptosis, link the op-CaMKII-mediated regulation of caspase-2, thereby pro-
viding insight into the control of germ-cell life and
death.
Results
G6P Inhibits Apoptosis in Xenopus Egg Extracts
If nutrient depletion contributed to apoptotic induction
in Xenopus eggs and oocytes, we hypothesized that
boosting glucose-utilizing metabolic pathways might
forestall apoptosis in this system. Accordingly, we
added G6P directly to the in vitro egg extract system
and monitored cleavage of the model substrate, DEVD-
pNA, as a measure of caspase-3 activity. As shown in
Figure 1A, the caspase-3 activation observed following
incubation of the extract at room temperature was en-
tirely suppressed by G6P addition. Note that G6P,
which in oocytes is derived largely from gluconeogene-
sis or glycogenolysis, was used in these experiments
rather than glucose due to the presence of very low
hexokinase activity in these extracts (C.E.H. and L.K.N.,
unpublished data). We also found that G6P could inhibit
apoptotic fragmentation of sperm nuclei added to egg
extracts (Figure 1B). Consistent with the critical role for
mitochondria in the induction of Xenopus egg apopto-
sis, the suppressive effects of G6P could be seen at the
level of cytochrome c release (Figure 1A, lower panel).
Moreover, the inhibitory effect of G6P on caspase acti-
vation and cytochrome c release could be overridden
by addition of truncated Bid (tBid) to forcibly promote
cytochrome c release (Figure 1C). These data indicate
that G6P-containing extracts were still capable of acti-
vating caspases and that the observed block to apo-
ptosis following G6P treatment occurred upstream of
or at the level of the mitochondria.
Pentose-Phosphate-Pathway Intermediates
Suppress Cell Death
In Xenopus eggs/oocytes, G6P is used for glycogen de-
position or is metabolized through the pentose phos-
phate pathway. Indeed, the fate of radiolabeled G6P
has been followed in amphibian oocytes, and little is
metabolized by glycolysis (Dworkin and Dworkin-Rastl,
1989). Consistent with this, we found that glycolytic
intermediates, including glyceraldehyde-3-phosphate
and pyruvate, had no effect on caspase-3 activation in
egg extracts (Figure 1D). In contrast, 6-phosphogluco-
nate, a pentose-phosphate-pathway intermediate, could
mirror the ability of G6P to inhibit apoptosis (Figure 1E).
These data suggested that some feature of pentose-
phosphate-pathway operation could suppress apopto-
sis. A key metabolic by-product of the pentose phos-
phate pathway is NADPH, produced when G6P is
Cell
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Hypothesizing that production of NADPH might be the
relevant consequence of G6P addition for apoptotic in-
hibition, we sought to generate NADPH using an alter-
native route and to examine the effects of direct
NADPH addition to extracts. Addition of malate, which
promotes NADPH production in concert with malic en-
zyme, potently inhibited mitochondrial cytochrome c
release and caspase activation in the egg extract (Fig-
ure 1F). Moreover, despite its relative instability in solu-
tion, NADPH could markedly suppress caspase activa-
tion (Figure 1E). These data suggest that G6P flux
through the pentose phosphate pathway, leading to
NADPH production, can potently suppress egg extract
apoptosis. Although NADPH can act as a reducing
agent, we do not believe that it is this feature of NADPH
function that is responsible for apoptotic suppression
as neither the SOD mimetic MnTBAP, the electron scav-
enger NAC, nor other reducing agents (TEMPO or re-
duced glutathione) could suppress extract apoptosis
(Figure 1G and data not shown).
Pentose-Phosphate-Pathway Inhibition Induces
Apoptosis in Egg Extracts and Oocytes
Since hyperstimulation of the pentose phosphate path-
way or NADPH addition inhibited caspase activation,
we speculated that inhibition of the endogenous pen-
tose phosphate pathway in egg extracts should accel-
erate apoptosis, particularly if the spontaneous extract
apoptosis relied upon nutrient depletion during incuba-
tion. To test this, we treated extracts with the G6P de-
hydrogenase inhibitor, dehydroisoandrosterone (DHEA),
to prevent entry of endogenous G6P into the pentose
phosphate pathway (Schwartz and Pashko, 2004). This
treatment accelerated apoptosis, largely eliminating
the lag normally seen before caspase activation, as
would be expected if pentose-phosphate-pathway
function were important for extract “survival” (Figure
2A). We also examined extracts to determine whether
endogenous G6P was depleted over time upon incuba-
tion. For this purpose, extracts were incubated at room
temperature and assayed for caspase activation (Figure
2B, top panel). Aliquots of extract withdrawn at the
start of the incubation (0 hr) or just prior to caspase
activation (2 hr) were incubated with a vast excess of
G6P dehydrogenase and NADP and assayed over time
for generation of NADPH, which, under these circum-
stances, depended solely on the available G6P. As
shown in Figure 2B (middle panel), G6P levels (as mea-
sured by the rate of NADPH generation) dropped sub-
stantially within the 2 hr of incubation. Note also that
NADPH generation remained high in extracts supple-
mented with excess G6P (Figure 2B, lower panel).
We wished to extend these observations to whole
oocytes to determine if the pentose phosphate path-
way was important for suppressing death in these in-
tact cells. For this, we developed a visual assay for oo-
cyte death. Normally, oocytes contain a light-colored
vegetal half and a dark, uniformly pigmented animal
half. When induced to undergo maturation with proges-
terone, oocytes exhibit a white spot resulting from
nuclear-envelope breakdown and clearance of sur-
rounding pigment granules. We noted that a similar but
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Gonsiderably larger white spot appeared at the animal
oles of oocytes injected with cytochrome c to induce
aspase activation (C. Holley, personal communica-
ion). These oocytes did not exhibit elevated Cdc2/
yclin kinase activity characteristic of maturing oocytes
ut rather showed high levels of caspase-3 activity
data not shown). Morphological events of apoptosis
ave been observed in oocytes by others, both in Xen-
pus and in other species (Bagowski et al., 2001; Bhu-
an et al., 2001; Braun et al., 2003; Demirci et al., 2001,
002, 2003; Voronina and Wessel, 2001). Interestingly,
e had observed that oocytes taken freshly out of a
irgin female frog are remarkably refractory to apopto-
is. With the idea that this resistance might stem from
ontinual functioning of the pentose phosphate path-
ay, we soaked fresh oocytes in a DHEA-containing so-
ution and monitored the appearance of large white
pots at the animal poles. As shown in the micrographs
n Figure 2C and the graph in Figure 2D, 200 M DHEA
apidly killed oocytes, while control treated oocytes re-
ained healthy. These data were corroborated in ex-
eriments where cytochrome c was released from mito-
hondria in DHEA-treated but not control oocytes
Figure 2E). Importantly, this acceleration of oocyte
eath occurred at even lower doses of DHEA (100 M)
nd could be reversed by simultaneous treatment with
he cell permeant D-methylmalate, which would be ex-
ected to promote NADPH generation within oocytes
Figure 2F). These data demonstrate that pentose-
hosphate-pathway inhibition promotes rapid oocyte
eath, suggesting that this pathway is normally critical
or oocyte viability.
aspase-2 Is a Target of NADPH-Mediated
poptotic Inhibition
ince G6P (or NADPH) could inhibit apoptosis, we
ished to identify the target of this inhibition. As men-
ioned above, genetic analyses in mice had implicated
aspase-2 as an important constituent of oocyte apo-
totic pathways (Bergeron et al., 1998). To determine
f caspase-2 was affected by G6P, we first examined
rocessing of radiolabeled caspase-2 during spontane-
us apoptosis. As shown in Figure 3A, addition of G6P,
entose-phosphate-pathway intermediates, malate, or
ADPH all prevented caspase-2 processing, while gly-
olytic intermediates had no effect. Moreover, G6P
nhibited endogenous caspase-2 processing, as de-
ected by immunoblotting (Figure 3H). Caspase-2 pro-
essing in untreated extracts was inhibitable by the ba-
uloviral caspase inhibitor p35 and the peptide inhibitor
f caspase-2, VDVAD-fmk, but was not inhibited by Bcl-
L, which prevented cytochrome c release and cas-
ase-3 activation (Figures 3B, 3C, and 3E). Interest-
ngly, treatment with p35 or VDVAD-fmk also inhibited
ytochrome c release, consistent with the involvement
f a caspase (potentially caspase-2) upstream of mito-
hondria in this system (Figures 3D and 3E). Moreover,
either caspase-2 processing nor cytochrome c release
ould be inhibited by the pancaspase inhibitor, z-VAD-
mk, consistent with previous reports that caspase-2 is
arkedly less sensitive to zVAD than other caspases
Garcia-Calvo et al., 1998) (Figures 3B and 3D). Thus,
6P could inhibit the z-VAD-insensitive, p35- and
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93Figure 2. Inhibition of G6P Dehydrogenase Induces Apoptosis
(A) Extracts supplemented with either dehydroisoandrosterone (DHEA) or buffer were analyzed for caspase-3 activity. Shown is a representa-
tive experiment repeated on three separate batches of oocytes with similar results.
(B) Upper panel: extract was incubated at room temperature and assayed for caspase activity. Middle panel: samples withdrawn at 0 and 2
hr of incubation were assayed for G6P levels by monitoring NADPH production over time (absorbance at 340 nm) in the presence of excess
G6P dehydrogenase and NADP. Lower panel: addition of excess G6P maintained NADPH production at all times tested. Dotted line indicates
the fact that the scales are different in the extracts ± G6P, as NADPH was produced at much higher rates in the presence of excess G6P.
(C) Oocytes treated with DHEA or buffer are shown in representative micrographs.
(D) Percent survival of oocytes treated with buffer or DHEA.
(E) Cytochrome c release was measured in parallel by filtering aliquots of lysed oocytes through a 0.1 m microfilter and analyzing the filtrate
by anti-cytochrome c immunoblotting.
(F) Percent survival of oocytes treated with buffer, DHEA, or DHEA and cell-permeable D-methyl malate.
Cell
94Figure 3. Pentose Phosphate Metabolites Act Upstream of Cytochrome c Release
(A) Egg extract was incubated with metabolic substrates, and samples were analyzed for processing of in vitro-translated caspase-2.
(B) Extract was incubated at room temperature in the presence of caspase inhibitors (zVAD, 100 M; VDVAD, 100 M; or p35) and radiolabeled
procaspases. Samples from time 0 (T0) and 7 hr (T7) were analyzed by SDS-PAGE for processing of in vitro-translated caspase-2 (C2), -3 (C3),
and -9 (C9).
(C) Extract was incubated at room temperature ± Bcl-xL, and samples were analyzed every hour for in vitro-translated C2 and C3 processing
by SDS-PAGE and for cytochrome c release.
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(D) Upper panel: egg extract was incubated at room temperature and treated with or without p35 and zVAD-fmk. Samples were taken every
hour, mitochondria were removed by filtration, and the remaining cytosol was immunoblotted with anti-cytochrome c antibody. Lower panel:
same as above, except a 7 hr time point is shown also in the presence of VDVAD.
(E) Upper panel: samples were treated as in (D), but in the presence of VDVAD. Lower panel: processing of radiolabeled caspase-2 was
monitored ±VDVAD.
(F) Cleavage of VDVAD-pNA was monitored in extracts containing buffer, malate, or G6P.
(G) Oocytes were treated with DHEA as in Figure 2A, with or without prior soaking in buffer containing the indicated concentrations of VDVAD.
(H) Cleavage of endogenous caspase-2 was monitored ±G6P by anti-caspase-2 immunoblotting using a mix of C20 and H119 antibodies
from Santa Cruz, which recognize only the full-length 48 kDa protein and the 12 kDa cleavage fragment, indicated by the arrow. The asterisk
indicates a background band present in all lanes.
all kinases were active against their model peptide sub-VDVAD-sensitive processing of caspase-2, most likely
catalyzed by caspase-2 itself. Consistent with these
observations, G6P blocked cleavage of the peptide
substrate VDVAD-pNA (Figure 3F). In addition, VDVAD,
which inhibited both caspase-2 processing and cyto-
chrome c release in egg extracts, could block the
DHEA-induced apoptosis of oocytes (Figure 3G). These
data agree with the idea that caspase-2 is a critical in-
hibitory target of pentose-phosphate-pathway metabo-
lites.
G6P and NADPH Prevent Activation
of Caspase-2 by RAIDD
Caspase-2 is activated by oligomerization through
binding of its CARD to adaptors (Duan and Dixit, 1997).
Although our data suggested that G6P and NADPH
could inhibit caspase-2, it was not clear that this inhibi-
tion was exerted at the level of caspase-2 rather than
indirectly through inhibition of an upstream signaling
component. To address this, we wished to promote di-
rect caspase-2 oligomerization and determine if this,
too, could be inhibited by G6P. The adaptor RAIDD
binds to the caspase-2 CARD and has been implicated
in caspase-2 activation in several settings. We have
found that GST-RAIDD bound to glutathione Sepharose
can, upon addition to egg extracts, directly promote
caspase-2 processing (Figure 4A). Even this caspase-2
autoprocessing was inhibited by G6P or NADPH, sug-
gesting that NADPH can interfere with direct RAIDD-
induced caspase-2 activation (Figure 4A). Moreover,
G6P or NADPH decreased the total amount of caspase-2
that could be retrieved from extracts in association with
Sepharose-RAIDD, suggesting that these metabolites
could interfere with adaptor-caspase-2 complex for-
mation (Figure 4B). Similar results were obtained using
in vitro-translated human caspase-2, whose processing
was also inhibited by G6P and VDVAD in the egg ex-
tract (Figures 4C–4E). These data suggest that meta-
bolic inhibition of caspase-2 can be exerted directly at
the level of oligomerization/activation.
G6P and NADPH Promote Caspase-2
Phosphorylation by CaMKII
Since G6P and NADPH blocked activation of caspase-2
by RAIDD, we suspected that either these proteins
were posttranslationally modified to prevent their in-
teraction or a CARD binding inhibitor was recruited in
the presence of G6P. Experiments to detect proteins
bound to either GST-RAIDD or the GST-caspase-2 pro-
domain did not reveal any potential inhibitors bound
only in the presence of G6P (data not shown). There-of these proteins might be posttranslationally modified.
Thus, we looked to see whether GST-RAIDD or the GST-
caspase-2 prodomain was phosphorylated in G6P-
treated extracts. Although we saw no evidence of RAIDD
phosphorylation, G6P addition greatly stimulated phos-
phorylation of the caspase-2 prodomain, derived from
either human or Xenopus caspase-2 (Figure 5A and data
not shown). The caspase-9 prodomain was not phos-
phorylated under these conditions (Figure 5A). Note
that prolonged exposure of kinase-assay gels revealed
basal phosphorylation of the caspase-2 prodomain in
untreated extracts, but this was markedly stimulated by
G6P (Figures 5A and 5B). Moreover, endogenous pro-
caspase-2 immunoprecipitated from egg extracts incu-
bated with [γ-32P]ATP was also phosphorylated, and this
phosphorylation was stimulated by G6P (Figure 5C).
To identify the kinase (or kinases) phosphorylating
the caspase-2 prodomain, we repeated the experiment
in Figure 5B in the presence of a battery of kinase inhib-
itors. Inhibition of several kinases previously implicated
in apoptotic regulation, including PKC, PKA, AKT, and
MEK, had no effect on G6P-stimulated caspase-2
phosphorylation (Figure 5D and data not shown). How-
ever, UCN-01 blocked phosphorylation of the caspase-2
prodomain (Figure 5D). Although UCN-01 is a broad-
spectrum kinase inhibitor, it has been used extensively
in Xenopus egg extracts to inhibit both Chk1 and CaMKII
(Graves et al., 2000; Hutchins et al., 2003). The inability
of caffeine, an inhibitor of Chk1-activating kinases, to
override G6P suggested Chk1 might not play a role in
this pathway (Figure 5D). Indeed, Chk1 immunodeple-
tion produced no loss of G6P-stimulated prodomain
phosphorylation (Figure 5E). Conversely, treatment of
egg extracts with the general CaMK inhibitor, KN93, led
to a substantial loss of G6P-stimulated caspase-2
phosphorylation (Figure 5F). Moreover, depletion of ex-
tracts using calmodulin Sepharose or treatment of
extracts with the calmodulin inhibitors W7 or W13
markedly diminished G6P-triggered phosphorylation of
caspase-2, consistent with the involvement of a calmod-
ulin binding protein in this pathway (Figures 5G and 6D).
Moreover, excess calcium stimulated and EGTA inhib-
ited phosphorylation of the caspase-2 prodomain, con-
sistent with the involvement of a calcium-regulated ki-
nase (Figure 6C).
To determine if CaMKs could phosphorylate the cas-
pase-2 prodomain, we incubated the GST prodomain
in vitro with [γ-32P]ATP and either CaMKI, CaMKII, or
CaMKIV. Only CaMKII could phosphorylate the recom-
binant caspase-2 prodomain (CaMKII could also phos-
phorylate the human caspase-2 prodomain), although
Cell
96Figure 4. Antiapoptotic Effects of NADPH Are Exerted at the Level of Caspase-2
Error bars indicate the standard deviation of triplicate samples.
(A) GST-RAIDD or GST bound to glutathione Sepharose was dipped into extract ± NADPH or G6P in the presence of radiolabeled procaspase-2.
Beads were retrieved by centrifugation, boiled in SDS sample buffer, and resolved by SDS-PAGE for autoradiography. Procaspase-2 not
bound to beads was also unprocessed in the presence of G6P or NADPH (data not shown).
(B) GST-RAIDD Sepharose was dipped into extracts with in vitro-translated caspase-2 in the presence and absence of NADPH. Beads were
washed extensively, and radiolabeled caspase-2 binding was measured by phosphoimager.
(C) The same experiment in (B) was repeated using in vitro-translated human, rather than Xenopus, caspase-2.
(D) Processing of radiolabeled human procaspase-2 supplemented into egg extracts was monitored in the presence and absence of G6P.
(E) The same as in (D), but ±VDVAD.
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97Figure 5. G6P/NADPH Induces Phosphoryla-
tion and Inactivation of Caspase-2
Error bars indicate the standard deviation of
triplicate samples.
(A) Upper panel: the GST prodomain of Xen-
opus caspase-2 (C2) or -9 (C9) was bound to
glutathione Sepharose and dipped into cyto-
solic extracts ± G6P and [γ-32P]ATP. Bead
bound proteins were washed and analyzed
by SDS-PAGE and phosphorimaging. Lower
panel: similar results were obtained with the
human caspase-2 prodomain.
(B) The experiment in (A) was repeated mi-
nus G6P and overexposed to detect basal
caspase-2 phosphorylation.
(C) Anti-Xenopus caspase-2 prepared against
a C-terminal 20 amino acid peptide or preim-
mune antibodies were bound to protein A
beads and dipped into extract ± G6P and
[γ-32P]ATP. Samples were resolved by SDS-
PAGE and detected by autoradiography.
(D) The experiment in (A) was repeated with
5 mM caffeine, UCN-01 (1 M), or Akt inhibi-
tor (20 M). Sepharose bound GST proteins
were washed and analyzed by SDS-PAGE
and quantitated by phosphorimaging.
(E) Egg extracts were depleted with anti-Chk1
or control antibody and incubated with G6P.
Samples were washed and analyzed by SDS-
PAGE and autoradiography (upper panel) or
anti-Chk1 immunoblotting (lower panel).
(F) The experiment in (A) was repeated with
5 M KN-93. Sepharose bound GST proteins
were washed and analyzed by SDS-PAGE
and quantitated by phosphorimaging.
(G) Egg extracts were depleted with calmod-
ulin Sepharose or control Sepharose and then
incubated with G6P. Caspase-2 prodomain
phosphorylation was monitored as in (A).
Cell
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Figure 6. CaMKII Phosphorylates the Prodomain of Caspase-2
Error bars indicate the standard deviation of triplicate samples.
(A) Left: in vitro kinase assays were performed with either buffer, CaMKI, CaMKII, or CaMKIV and the GST-fused prodomain of caspase-2 (wt
or S135A). Prodomain phosphorylation was analyzed by SDS-PAGE, and the gel was stained with Coomassie blue to show equal loading.
Middle: the same assay was performed using CaMKII and the human caspase-2 prodomain. Right: the activity of each kinase was tested
against its cognate peptide substrate and compared to substrate (S) alone in the absence of kinase.
(B) Left panel: extract was incubated ±G6P, [γ-32P]ATP, and the peptide substrate Syntide-2 (Syn2) ± various doses of a CaMKII peptide
inhibitor (CaMKII 281-309). Substrate trapped on filter paper was washed extensively and scintillation counted. Right panel: the same extracts
were tested using the GST-caspase-2 prodomain as substrate by the same protocol as in Figure 5A. Shown is the quantitation of GST-
caspase-2 prodomain phosphorylation from three gels exposed to the indicated inhibitor doses.
(C) Upper left panel: a representative gel showing inhibition of caspase-2 phosphorylation by the 281-309 peptide (as in the right-hand panel
of [B]) and Ca2+-stimulated phosphorylation of GST (G) and the GST prodomain of caspase-2 (C2). Lower left panel: quantitation of the gel.
Right panel: the assay in Figure 5A was repeated in the presence of EGTA.
(D) Using the same conditions as in (B), another CaMKII inhibitor (5 M AIP) was tested using its peptide substrate AC-3 (left panel). Right
panel: calmodulin inhibitors (10 M W13 and 10 M W7) were tested in the same manner as in (C) using the GST-caspase-2 prodomain
as substrate.
tion did not have similar effects, pointing to the speci-strates (Figure 6A, right). More importantly, two specific
peptide inhibitors of CaMKII (Ca2+/calmodulin kinase II
inhibitor 281-309 and autocamtide-2-related inhibitory
peptide) could prevent G6P-induced phosphorylation
of both a model CaMKII substrate and the caspase-2
prodomain (Figures 6B–6D). These data strongly sug-
gest that CaMKII mediates G6P-stimulated caspase-2
phosphorylation.
Abrogation of Caspase-2 Phosphorylation Prevents
Metabolite-Mediated Survival
Given the involvement of CaMKII in caspase-2 phos-
phorylation, we scanned the caspase-2 prodomain for
sequence motifs characteristic of CaMK phosphoryla-
tion sites and identified Ser73 and Ser135 as candidate
sites; these were individually changed to Ala. When we
assayed these mutants in egg extracts, we found that
both G6P and NADPH-stimulated prodomain phos-
phorylation were abrogated by the S135A mutation but
were unaffected by Ser73 alteration (Figure 7A). Ser135
mutation also prevented in vitro phosphorylation by
CaMKII (Figure 6A). To determine if this site was critical
for metabolic suppression of caspase-2, we produced
mRNA and in vitro-translated proteins for full-length
wild-type, S135A, and S73A caspase-2. As shown in
Figure 7B, the S135A protein was processed even in
the presence of G6P. More importantly, mutation of
Ser135 to Ala not only overrode the G6P-mediated
block to spontaneous caspase-3 activation in egg ex-
tracts but also overrode the inhibition of RAIDD-
induced processing and binding to caspase-2 (Figures
7C and 7D and data not shown). Strikingly, the S135A
mutant also induced apoptosis in oocytes (Figure 7E).
Consistent with a role for CaMKII in suppressing cas-
pase-2-mediated death of intact oocytes, prior injec-
tion of the CaMKII peptide inhibitor allowed efficient
cell-death induction by subsequent injection of the wt
procaspase-2 mRNA (Figure 7F). These data demon-
strate that metabolic suppression of caspase-2 in eggs
and oocytes is exerted through CaMKII-mediated phos-
phorylation of the caspase-2 prodomain.
Discussion
Although it has long been appreciated that oocytes dieof these cells have not yet been fully described (Tilly,
2001). Here we have provided evidence for a molecular
pathway linking metabolic processes with the survival
of oocytes/eggs. The target of this pathway, caspase-2,
has been previously implicated in oocyte apoptosis
(Bergeron et al., 1998). We have found that stimulation
of the pentose phosphate pathway, leading to NADPH
generation, can restrain caspase-2 via the action of
CaMKII, thereby promoting oocyte/egg survival.
Oocyte/Egg Metabolic Pathways and Apoptosis
Studies on metabolic flux in Xenopus oocytes have
demonstrated that glycolysis is low in these cells and
that the majority of carbon that could enter glycolytic
pools is, instead, rapidly converted to glycogen (Dwor-
kin and Dworkin-Rastl, 1989). However, this glycogen
is not metabolized until after gastrulation and does not
serve as an energy source to support early embryogen-
esis (Cohen, 1954; Jaeger, 1945). Rather, it has been
proposed that amino acids derived from yolk-protein
breakdown can be partially oxidized to malate in mito-
chondria, which is then oxidized to oxaloacetate and
converted to phosphoenolpyruvate to generate G6P
(Dworkin and Dworkin-Rastl, 1989; Kovacevic and Mor-
ris, 1972; Maller, 1985; Reitzer et al., 1979). According
to this scenario, yolk proteins serve as the source of
energy for the oocyte and early embryo. Our observa-
tions suggest that maintenance of G6P levels from ade-
quate yolk-protein stores can prevent death of oocytes
and eggs. It is worth noting that the amount of G6P
required to achieve full inhibition of apoptosis in egg
extracts is quite high (i.e., greater than 2.5 mM). Consis-
tent with previous measurements of radiolabeled G6P
flux in amphibian oocytes, we believe that the vast ma-
jority of the added G6P is shunted directly into glyco-
gen synthesis and that only a small amount is available
to enter the pentose phosphate pathway (Dworkin and
Dworkin-Rastl, 1989; Ureta et al., 2000). Within the ani-
mal, such levels could be maintained as long as yolk-
protein stores were continually feeding G6P production.
Because stimulation of pentose-phosphate-pathway
metabolism, malate, or NADPH could substitute for
G6P to inhibit apoptosis, our data suggest that it is
NADPH generation that transmits the antiapoptotic sig-
nal. Addition of NADH or stimulation of NADH produc-
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100Figure 7. Mutation of S135 of Caspase-2 to Ala Abrogates the Protective Effects of NADPH
(A) The wt, S73A, and S135A caspase-2 prodomains fused to GST were bound to glutathione Sepharose and dipped into cytosolic extracts ±
G6P, ± NADPH, and [γ-32P]ATP. Sepharose bound proteins were washed, eluted with sample buffer, and resolved by SDS-PAGE.
(B) Extracts supplemented with wt, S135A, or S73A radiolabeled procaspase-2 were incubated at room temperature and treated with or
without G6P. Samples were taken at the indicated times and analyzed by SDS-PAGE.
(C) Procaspase-2 S135A or wt mRNA and G6P were added to a translationally competent egg extract, and samples were taken to measure
cleavage of Ac-DEVD-pNA.
(D) GST-RAIDD was added to extracts with in vitro-translated wt or S135A procaspase-2 ± G6P for 1 hr. Samples were taken to measure
caspase-2 processing by SDS-PAGE.
(E) Oocytes were injected with mRNA encoding wt or S135A procaspase-2 or β-globin. Cell death was quantitated as in Figure 2. Shown is a
representative experiment repeated on three oocyte batches with similar results.
(F) Oocytes were injected with the 281-309 CaMKII inhibitory peptide, subsequently injected with wt procaspase-2-encoding mRNA, and
monitored as in (E).
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101ficity of our results (Figures 1D and 3A and data not
shown). Also consistent with the involvement of pen-
tose-phosphate-pathway operation are our observa-
tions that inhibition of G6P dehydrogenase could accel-
erate caspase activation in both egg extracts and
oocytes. Although the initiator of spontaneous death in
the Xenopus egg system has not been previously iden-
tified, our data suggest that an active signaling system
is engaged to keep these cells alive and that the default
pathway, when key metabolites cannot be maintained,
is cell death.
Although it is attractive to speculate that nutrient
stockpiles serve as a timer for oocyte survival, changes
in pentose-phosphate-pathway flux might also result
from age- or hormone-related alterations in enzyme
activities. Indeed, age-related decreases in G6P dehy-
drogenase activity have been observed in mouse oo-
cytes, and it has been suggested that, even if such oo-
cytes survive, they may develop poorly postfertilization
(de Schepper et al., 1987).
Caspase-2 Is a Target for the Antiapoptotic
Action of NADPH
A previous report that caspase-2 was required for oo-
cyte apoptosis led us to investigate caspase-2 as a po-
tential target of metabolic regulation (Bergeron et al.,
1998). In addition to our observation that caspase-2
processing was inhibited by G6P or NADPH, the fact
that a caspase-2 mutant resistant to phosphorylation
could override the effects of G6P in egg extracts as well
as the natural resistance of intact oocytes to apoptosis
strongly suggests that caspase-2 is an important target
of metabolic survival pathways.
It is not clear how caspase-2 is activated in oocytes.
However, based on the ability of RAIDD-mediated acti-
vation to be regulated by NADPH and G6P, we hypothe-
size that an endogenous adaptor protein binding to the
caspase-2 prodomain promotes activation; phosphory-
lation of the prodomain could block access of the
adaptor, preventing activation. Consistent with such a
possibility, caspase-2 binding to GST-RAIDD was sub-
stantially reduced by G6P and NADPH addition.
CaMKII Phosphorylates and Inhibits Caspase-2
Based on calmodulin Sepharose depletion, kinase as-
says, and inhibitor studies, we conclude that CaMKII
maintains caspase-2 phosphorylation in response to
pentose-phosphate-pathway operation. Although this
phosphorylation was stimulated by G6P, we note that
basal phosphorylation could be observed upon longer
exposure of kinase assays. We suggest that basal
phosphorylation can keep caspase-2 suppressed and
that dephosphorylation occurs prior to entry of extracts
into apoptosis. Consistent with this, the GST-caspase-2
prodomain prephosphorylated with CaMKII loses its ra-
dioactive labeling immediately preceding caspase-3 acti-
vation in the extract (L.K.N. and S.S.M., unpublished
data). We were able to maintain this phosphorylation
through the simple provision of metabolites.
Although our data demonstrate that CaMKII activity
is required for maintaining caspase-2 suppression in re-
sponse to nutrients, it is not yet clear how NADPH
levels are translated into sustained phosphorylation. Itis possible that a caspase-2-directed phosphatase is
regulated to antagonize constitutive CaMKII-mediated
caspase-2 phosphorylation supported by ambient cal-
cium levels in the egg/oocyte. However, the fact that
CaMKII phosphorylation of model peptides (which we
might not expect to be targeted for dephosphorylation
by the same phosphatases as the prodomain) was in-
creased following G6P/NADPH treatment suggests that
these metabolites may increase CaMKII activation or
activity. It is possible that a phosphatase controlling
CaMKII activity (through regulation of the CaMKII-acti-
vating phosphorylation at Thr286 as observed in other
settings) is regulated by NADPH (Blitzer et al., 1998). It
is not clear whether pathways regulating calcium stor-
age or utilization may also be regulated by NADPH to
control CaMKII activation. In any event, the spontane-
ous activation of the S135A mutant caspase-2 (even in
cytosol lacking mitochondria; data not shown) demon-
strates that maintenance of this phosphorylation is crit-
ical to keep eggs/oocytes alive. Because processing of
the S135A mutant was slightly slower in the presence
of G6P (see Figure 7B), it may be that additional modes
of caspase-2 regulation (or targets other than cas-
pase-2) contribute to G6P-mediated apoptotic sup-
pression. However, S135 is clearly a major target of this
regulatory pathway. Moreover, because there is still a
lag time until apoptosis in the presence of the S135A
mutant, pathways in addition to the CaMKII-caspase-2
pathway may contribute to the normal suppression of
apoptosis in oocytes/eggs. Although further experi-
ments will be required to fill in the precise regulatory
details, this work has revealed key elements of a pre-
viously unknown pathway linking oocyte metabolism to
caspase-2 through the action of CaMKII. This work may
help to explain why oocytes are lost through apoptosis
as females age, thereby providing potential therapeutic
targets for the maintenance of oocyte viability and fer-
tility.
Experimental Procedures
Preparation of Xenopus Oocytes and Extracts
Egg extracts were prepared as in Smythe and Newport (1991).
Stage VI oocytes were prepared from ovaries manually excised
from PMSG-primed frogs, digested with 2.8 units of liberase in
OR-2 buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES
[pH 7.5]) for 1.5 hr at room temperature, washed extensively with
OR-2 buffer, and stored in OR-2 buffer + 1% fetal bovine serum +
0.2% gentamicin at 18°C.
Caspase Assays and Metabolite Addition
To measure caspase activity, 3 l extract aliquots were incubated
with 90 l DEVDase buffer (50 mM HEPES [pH 7.5], 100 mM NaCl,
0.1% CHAPS, 10 mM DTT, 1 mM EDTA, 10% glycerol) and the sub-
strate Ac-DEVD-pNA (200 M) at 37°C for 30–60 min. Absorbance
was measured at 405 nm. For some experiments, extracts were
treated with G6P (2.5–10 mM), NADPH (5–10 mM), or other metabo-
lites (all 10 mM). Other reagents were used at 100 M (zVAD), 500
nM (Bcl-xL), and 25 nM (tBid).
Xenopus Oocyte Apoptosis Assays
For pentose-phosphate-pathway inhibition studies, w50 stage VI
Xenopus oocytes were incubated with vehicle, 100–200 M DHEA,
and/or 2.5 mM methyl malate in OR-2 buffer at 16°C. For caspase-2
potency studies, 40 ng of wt, S73A, and S135A mutant caspase-2
or β-globin-encoding mRNA was injected into oocytes and incu-
bated in OR-2 buffer at 16°C. To measure cytochrome c release,
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102oocytes were manually lysed in 10 l lysis buffer/oocyte (20 mM
HEPES [pH 7.5], 20 mM β-glycerophosphate, 15 mM MgCl2, 20 mM
EGTA, 1 mM PMSF, 10 g aprotenin/leupeptin) and spun at 14,000 ×
g for 5 min. Samples were filtered through a 0.1 m ultrafree-MC
filter and immunoblotted for cytochrome c.
Protein Expression and Reagents
Xenopus caspase-2 was amplified by PCR using the primers 5#-
CGCGGATCCATGCTGGGAGGCATGCAGCAAC-3# and 5#-GACGG
ATCCTCACTTGGGGAGCCCGTTGCTTGG-3#. Purified PCR prod-
ucts were digested and cloned into the BglII site of pSP64T, an
expression vector with flanking 5# and 3# β-globin UTRs. The
QuikChange Site-Directed Mutagenesis Kit (Stratagene) was used
to generate point mutants in caspase-2 in pSP64T. The S73A prim-
ers were 5#-GCAGAGCATTGCAGAATGCTGCAAAAGCACGTGGAC
CCC-3# and its complement. The S135A primers were 5#-GCAGA
GAGTACAGGGAAGAGGCTATTGATGATGGAGATGG-3# and its com-
plement.
To produce radiolabeled proteins, pSP64T-caspase-2, -3, and -9
templates were translated in TNT reticulocyte lysates (Promega)
containing 1 Ci/l 35S-Translabel according to manufacturer’s in-
structions. mRNA for microinjection was generated using the Stra-
tagene mRNA capping kit.
The wt, S73A, and S135A caspase-2 prodomains were amplified
by PCR using the pSP64T-caspase-2 clones as templates with the
primers 5#-CGCGGATCCATGCTGGGAGGCATGCAGCAAC-3# and
5#-TGCTCTAGATCATGGACCATCTCCATCATCAATAG-3#. PCR prod-
ucts were cloned into BamHI and XbaI sites of pGEXKG. pGEXKG
caspase-2 and RAIDD proteins were expressed in BL21 E. coli as
in Evans et al. (1997). GST-BCL-xL was a gift from M. Hardwick.
GST-human caspase-9 prodomain was expressed as in Deming et
al. (2004).
His-p35-encoding baculovirus was produced using the Invitro-
gen baculovirus expression system, and proteins were purified on a
nickel chelate column, eluted with 200 mM imidizole, and dialyzed
overnight into egg lysis buffer (ELB) (250 mM sucrose, 2.5 mM
MgCl, 1 mM DTT, 50 mM KCl, 10 mM HEPES [pH 7.7]).
Kinase Assays and Depletions
One to two micrograms of recombinant GST-prodomain fusion pro-
teins were incubated in egg extract with 20 Ci [γ-32P]ATP and vari-
ous metabolites in the presence or absence of CaMK inhibitors for
1 hr at room temp and retrieved on glutathione Sepharose. Similar
extracts were treated with caspase-2 antibody bound to protein A
sepharose to precipitate endogenous phosphorylated caspase-2.
Samples were washed, eluted with SDS-PAGE sample buffer, and
resolved by SDS-PAGE for autoradiography and quantitation by
phosphorimager.
For in vitro phosphorylation, recombinant CaM kinases and 1–2
g GST prodomains were incubated in kinase buffer (25 mM
HEPES [pH 7.5], 0.5 mM dithiothreitol, 10 mM MgCl2, 200 M ATP,
20 Ci/reaction [γ-32P]ATP, 1 M A. nidulans CaM, 1 mM CaCl2,
0.1% Tween 20) for 1 hr at room temperature. Reactions were
stopped with SDS-PAGE sample buffer and resolved by SDS-PAGE
for quantitation by phosphorimager.
CaM kinase activity was tested in 50 l kinase buffer (as above)
for 1 hr at room temperature. CaMKI and CaMKIV were assayed
using 200 M ADR1G (LKKLTRRASFSGQ) as a substrate; 60 M
Syntide-2 (PLARTLSVAGLPGKK) was used for CaMKII. To measure
CaMKII activity in the egg extract, 60 M Syntide-2 and 50 M
autocamtide were added to extract in the presence or absence of
CaMK inhibitors with 20 Ci/reaction [γ-32P]ATP. Reactions were
terminated by spotting 20 l onto p81 phosphocellulose filters fol-
lowed by washing in 75 mM phosphoric acid. Dried filters were
scintillation counted.
Egg extracts were depleted of CaM kinase by three 30 min
rounds of incubation with calmodulin Sepharose or control protein
A sepharose at 4°C.
RAIDD Assays
GST or GST-RAIDD proteins linked to glutathione Sepharose were
added to 100 l egg extract supplemented with energy mix, various
metabolites or drugs, and 35S-labeled wt or S135A caspase-2.
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ented with 300 mM NaCl and 0.1% Tween 20. Samples were
luted with sample buffer and resolved by SDS-PAGE for autoradi-
graphy.
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